ArticleActa neuropathologica communications2023

Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study.

Kohei Fukuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.